The Delta variant is producing different COVID-19 symptoms than usual, researchers say
The COVID-19 strain fueling infections across the U.K. is linked to a different set of symptoms, including headache, sore throat, and runny nose, BBC reported on Monday. The Delta variant, which was first found in India, now accounts for 90 percent of U.K. cases.
Professor Tim Spector, leader of the Zoe COVID Symptom Study, said top symptoms since the start of May are "not the same as they were" previously. Instead of the traditional cough, fever, and loss of taste and smell, infected individuals are now complaining of headache, sore throat, and runny nose, with fever and cough coming in fourth and fifth, respectively. Loss of smell doesn't even make the top 10, The Guardian writes.
Spector added that the Delta variant seems to be working "slightly differently," and that possible COVID-19 infection could feel "just like a bad cold or some funny 'off' feeling." As the new strain is reportedly more contagious and more likely to lead to hospitalizations, Spector urged the two-thirds of the U.K. still vulnerable to symptomatic infection — likely younger adults waiting for vaccines — to stay home and get tested should they feel sick, per the Guardian.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Delta variant now accounts for about 10 percent of cases in the U.S., The New York Times reports. The good news, however, is that data suggests "if you've been fully vaccinated, you remain protected, that the vaccines hold up." Read more at The New York Times and The Guardian.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
- 
Margaret Atwood’s ‘deliciously naughty’ memoirIn the Spotlight ‘Bean-spilling’ book by The Handmaid’s Tale author is ‘immensely readable’
 - 
Being a school crossing guard has become a deadly jobUnder the Radar At least 230 crossing guards have been hit by cars over the last decade
 - 
Sudoku medium: November 4, 2025The Week's daily medium sudoku puzzle
 
- 
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
 - 
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
 - 
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
 - 
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
 - 
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
 - 
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
 - 
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
 - 
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
 
